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Background: Functional constipation is a common disorder worldwide and is found in all paediatric age groups.
Functional constipation can be caused by delayed colonic transit or dysfunction of the pelvic floor muscles. Standard
medical care in paediatric practice is often based on clinical experience and mainly consists of a behavioural approach
and toilet training, along with the prescription of laxatives. Evidence to evaluate the effectiveness of pelvic physiotherapy
for this complaint is lacking.
Methods/design: A two-armed multicentre randomised controlled trial has been designed. We hypothesise that the
combination of pelvic physiotherapy and standard medical care will be more effective than standard medical care alone
for constipated children, aged 5 to 17 years. Children with functional constipation according to the Rome III will be
included. Web-based baseline and follow-up measurements, scheduled at 3 and 6 months after inclusion, consist of the
numeric rating scale in relation to the perceived severity of the problem, the Strength and Difficulties Questionnaire and
subjective improvement post-intervention (global perceived effect). Examination of the pelvic floor muscle functions,
including digital testing and biofeedback, will take place during baseline and follow-up measurements at the
physiotherapist. The control group will only receive standard medical care, involving at least three contacts during five
months, whereas the experimental group will receive standard medical care plus pelvic physiotherapy, with a maximum
of six contacts. The physiotherapy intervention will include standard medical care, pelvic floor muscle training, attention
to breathing, relaxation and awareness of body and posture. The study duration will be six months from randomisation,
with a three-year recruitment period. The primary outcome is the absence of functional constipation according to the
Rome III criteria.
Discussion: This section discusses the relevance of publishing the study design and the development of the presented
physiotherapy protocol. It also addresses difficulties when interpreting the literature with regard to the effectiveness of
biofeedback, potential confounding, and future research indications. To our knowledge, this article is the first to describe
the design of a randomised controlled trial among children with constipation to assess the effect of pelvic physiotherapy
as an add-on to standard medical care.
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Constipation is a common disorder worldwide, affecting
0.7% to 29.6% (median 12%) of children aged 0–18 years,
and is found in all paediatric age groups with a severity
that ranges from mild to severe and a duration that
ranges from brief to chronic [1-4]. Symptoms of consti-
pation are included in the Rome III criteria (Table 1),
which were formulated by paediatric gastroenterologists
in 2006 [3,5]. Constipation has a major impact on a
child’s psychosocial functioning. About 40% of these
children are burdened by emotional problems, such as
eating disorders, truancy, family problems, social isola-
tion and depression [6-10].
The pathophysiology of childhood constipation is
multifactorial and not yet fully understood. No clear or-
ganic cause is found in over 90% of the children who
suffer from constipation, so-called functional constipation
(FC). FC includes delayed colonic transit and dyssynergic
defaecation. In the majority of children dyssynergic defae-
cation is the cause for their complaints, and refers to an
incomplete evacuation of faeces due to paradoxical con-
traction of, or failure to relax the pelvic floor muscles
when straining and/or a failure to increase intra rectal
pressure [11,12]. In some patients, delayed colonic transit
may be the result of dyssynergic defaecation. Approxi-
mately 50% of children show this abnormal defecation
pattern [13]. Withdrawal of stool, hard painful defecation
or fear of stool, resulting in a vicious circle, is the most
commonly proposed explanation of the aetiology of dys-
synergic constipation in children [4,7,12,14-16].
The standard medical care (SMC) for FC children in
routine paediatric practice is often based on clinical ex-
perience and mainly consists of a behavioural approach
and toilet training along with the prescription of laxa-
tives, sometimes supported by disimpaction or a high
fibre diet [7,10,14,17,18]. Despite intensive medical and
behavioural treatment long-term follow-up studies have
shown that 50% of the children still have complaints of
constipation after five year follow up [19].Table 1 Paediatric Rome III criteria* for childhood
constipation
Must include two or more of the following in a child with a
developmental age of least four years
1 Two or fewer defaecations in the toilet per week
2 At least one episode of faecal incontinence per week
3 History of retentive posturing or excessive volitional stool retention
4 History of painful or hard bowel movement
5 Presence of a large faecal mass in the rectum
6 History of large diameter stools that may obstruct the toilet
*Criteria fulfilled at least once per week for at least two months prior to
diagnosis, with insufficient criteria for diagnosis of irritable bowel syndrome.Since dyssynergic dysfunction of the pelvic floor is the
major reason for FC in children, it is thought that pelvic
physiotherapists, who have specific expertise in treating
dyssynergic dysfunction, as musculoskeletal experts
might play an important role to increase the success
rate. All prerequisites for proper micturition and
defecation, such as a relaxed toilet posture [18,20], ad-
equate straining [18,21,22] and trunk stability [23-26],
are trained extensively. Pelvic floor muscle training in-
volves training the right use of the pelvic floor muscles
(PFM) during contracting and straining, breathing and
changes in abdominal pressure [21,22,27]. In case of
(urine) incontinence, the treatment can be extended
with additional PFM exercises.
Standard pelvic physiotherapy (PPT) care for the con-
stipated child has not been described. In most cases,
PPT consists of education, demystification, the use of mic-
turition and defecation diaries, toilet training, breathing
and relaxation exercises and pelvic floor muscle training
(PFMT), with PFMT including exercises and biofeedback
(BF) [28,29].
Methods/design
Trial design, hypothesis and research
To date, there has been little scientific evidence evaluat-
ing the effectiveness of pelvic physiotherapy (PPT) in
childhood constipation [7,14,29,30]. Therefore we de-
signed a two-armed multicentre randomised controlled
clinical trial (RCT). We hypothesise that the combination
of standard medical care (SMC) and PPT will prove more
effective than SMC alone for the treatment of FC in chil-
dren aged 5 to 17 years.
Secondary research questions are: (1) Does PPT add to
the child’s quality of life, as defined by the strengths and
difficulties questionnaire (SDQ), the numeric rating scale
(NRS) in relation to the perceived severity of the prob-
lem and the global perceived effect (GPE), (2) what
values of the pelvic floor muscle function (PFMF) in
children can be defined based on the results of the study
in clinically relevant subgroups, according to the inter-
national continence society (ICS) criteria.
Ethical approval
This study was registered in the Netherlands National
Trial Register (NL30551.068.09). The Medical Ethics
Committee of the Maastricht University Medical Centre
has approved the study. This study has been designed in
accordance with the Helsinki Accords and the Dutch
Medical Research Involving Human Subjects Act (WMO).
Framework of the study
A child’s participation to the study starts and ends with
a visit to a paediatrician. In our multicentre randomised
controlled trial, the control group will receive only
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perimental group will have SMC supplemented with
PPT (Figure 2). The control group will have at least
three contacts with the paediatrician in five months
while the experimental group will have a maximum of
six contacts with the physiotherapist. The study duration
will be six months from randomisation, with a three-
year recruitment period.
Measurement and timing
Web-based measurements will be obtained before the
first visit to the physiotherapist (M-WB 1), three months
after randomisation (M-WB 2) and before the final visit
to the physiotherapist (M-WB-3) (Figure 1). Shortly be-
fore randomisation (M-PPT 1) and at six month, adja-
cent to M-WB 3, measurements at the physiotherapist
will take place (M-PPT 2). After M-PPT 2 a final visit at
the paediatrician is scheduled.
Web-based measurements include a structured patient
reported outcome, which assesses the presence of the
Rome III criteria and laxative use, co morbidity (such asVisit to paediatrician
Web-based Baseline measurements:
NRS, Scoring lists: SDQ, MDD
PPT-PE
RANDOMISATION
Trial arm 1: SMC
Trial arm 2: SMC + PPT
PPT- PFE
Follow-up
Paediatrician : End of study
PPT - PFE
NRS: numeric rating scale
M-WB: Measurement, web-based
SDQ: Strenghts and Difficulties Questionnaire
MDD: micturition and defaecation diaries
PPT: pelvic physiotherapy
PPT-PE: physical examination
PPT: PFE pelvic floor examination
M-PPT: measurement at PPT practice
SMC:standard medical care
GPE: global perceived effect
Web-based Follow-up measurements
NRS, Scoringlists: SDQ, MDD, GPE
Web-based Follow-up measurements
NRS, Scoringlists: SDQ, MDD, GPE
(t = 0 months)
(t = 3 months)
(t = 6 months)







Figure 1 Flowchart of the randomised controlled trial.urinary problems and abdominal pain), the Strength and
Difficulties Questionnaire (SDQ), the numeric rating
scale (with regard to experienced burden) and a two
weeks diary. At follow-up (M-WB 2 and M-WB 3) the
web-based measurements are supplemented with the
global perceived effect (GPE).
At the last visit at the paediatrician, use of laxatives
and the presence of Rome-III-criteria (primary outcome)
are recorded.Participants
Study population
Children living in the Netherlands and referred to pelvic
physiotherapy by paediatricians from various hospitals
will be enrolled in this study.Inclusion criteria
(1) age 5–17 years, (2) functional constipation according
to the Rome III criteria, (3) attending regular schools,
(4) parent(s) sign(s) an informed consent, (5) children
aged over 11 years sign an informed consent themselves,
and (6) the child and parent(s) are motivated to partici-
pate in the study.Exclusion criteria
(1) prior physiotherapy because of defecation or mictur-
ition complaints, (2) urotherapy by another professional
(nurse, psychologist etc.) at the start of the study, (3) se-
vere delay in motor skills development, (4) endocrine
and metabolic disorders (hypothyroidism, hypercalcemia,
diabetes mellitus, diabetes insipidus), (5) neurological
and psychiatric disorders (spina bifida, cerebral palsy,
anorexia nervosa, autism or PDD-NOS), (6) Down Syn-
drome, (7) Hirschsprung disease, (8) at least 14 points
on the Strength and Difficulties Questionnaire, (9) drug-
induced constipation and (10) intestinal surgery (except
appendectomy).Interventions
Standard medical care
Standard medical care, provided by paediatricians, will
be given in accordance with the Dutch guideline for
constipated children (Figure 2) [18]. Essentially, standard
medical care consists of education and demystification
about the complaint, food, and drink and physical activ-
ity as well as toilet training and the use of diaries and
laxatives [18]. Usual care laxative use in children with
faecal impaction and older than two years is 1–1.5 g /kg
per day for a maximum of seven days. The maintenance
dose is 0.3 to 0.8 g/kg per day [18]. The dose will be tai-
lored to individual needs during the trial with guidance
of the Bristol Stool Form Scale [31].
Parents and children should receive information about
constipation and the expected results of treatment.
No extra fluid is recommended. There is insufficient
evidence to use extra fiber.
A normal movement pattern is recommended for every
child, with or without symptoms.
Constipated children are recommended, to go to the toilet
three times daily after meals (to use the gastroesophageal
reflex) for 5 minutes of training.
It is recommended to record daily defecation patterns in
diaries. Diaries can provide insight into symptoms such
as defecation, loss of stool, pain, etc. Additional
problems such as urinary incontinence and use of
laxatives may be recorded. The effectiveness of treatment





Micturition and defecation diaries
Laxatives Macrogol 3350 or 4000 as a laxative is recommended
Figure 2 Standard medical care in accordance with the ‘Dutch guideline on constipated children’.
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In order to standardise pelvic physiotherapy (PPT) for
these children, a survey was first held among 63 Dutch
specialised physiotherapists. Extensive agreement existed
on providing information, the use of diaries, toilet train-
ing, pelvic floor muscle training and biofeedback. On the
basis of the survey a provisional PPT protocol was
designed in consultation with 25 physiotherapists who
were experienced in treating constipated children, using









*DPPP: Dutch pelvic physiotherapy protocol
Figure 3 Development of the Dutch pelvic physiotherapy protocol foNext, the Delphi method was used to discuss, improve
and practise the interim protocol during three meetings
with all participating physiotherapists. The resulting
Dutch pelvic physiotherapy protocol (DPPP) (Figure 4)
provides standardisation of intake and intervention.
In this study, according to the DPPP, the PPT intake
will consist of medical history tracking, physical ex-
amination of at least balance and stability according to
M-ABC-2, [24,32,33] assessment of breathing and strain-
ing [21,22,25,26], the Beighton hyper mobility scoreim protocol Delphi procedure
11 specialised physiotherapists
DPPP*




r functional constipation in children.
PPT intake PPT intervention
medical history
· Including micturition, pain, comorbidity
and family history
PTT-PE
· Balance and stability
· Breathing
· Straining to defaecate




· Rectal balloon catheter
PPT: pelvic physiotherapy
PE: physical examination
PFE pelvic floor examination
MDD: micturition and defecation
diaries
TT: toilet training
PFMT: pelvic floor muscle training
ET: exercise therapy
MF: myofeedback





· information and demystification
· food and drink
· physical activity





· TT - body posture - straining to
defaecate - relaxation and breathing









· TT - straining to defaecate - relaxation





· TT - straining to defaecate - relaxation





· TT - relaxation and breathing - PFMT**






* Protocol deviations should be avoided unless there are urgent reasons for them
** Pelvic floor excercises include excercise therapy , MF and RBT. MT and/or RBT training is only applied in case of dysfunctional
pelvic floor muscles
Figure 4 Dutch pelvic physiotherapy protocol’*.
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their function [12,29].
The PPT intervention, with a maximum of six sessions
will include standard medical care (education, demystifi-
cation, toilet training, use of diaries and guiding the use
of laxatives without intervention of the paediatrician andpelvic floor muscle training using exercise therapy,
myofeedback (MFB) and rectal balloon training (RBT),
as well as attention to breathing, relaxation and aware-
ness of body and body posture. Awareness of urge and
coordination of the PFM during filling and straining will
be practised. During MFB, the child will receive
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by means of a visual display or a beeping sound. Chil-
dren with an insensitive rectum will be taught to excrete
smaller volumes and to repeat this action until a more
normal level of sensory threshold is reached. In the case
of an incorrect straining technique, RBT can be applied
to learn to strain adequately.
The PPT will be patient-tailored and the sequence
and intensity of PPT depends on the child's age and
motivation, parents` motivation, co-morbidity and cog-
nition. Toilet training, including pelvic floor muscle
training, will be the basis of the PPT and requires con-
siderable attention. All exercises, materials and methods
will be presented in a playful manner and in accord-
ance with the children’s age, loco motor skills and per-
ceptions [24,28,29,36].
Primary outcome measure
The primary outcome measure is the absence of FC
according to the Rome III criteria. The use of less than
10 g of macrogol 3350 or 4000 a day, as a maintenance
dose, is allowed.
Secondary outcome measures
– Numeric rating scale
The two single-item 1–10 numeric rating scales
(NRS) measure perceived severity of the problem by
the parents and estimate the child’s experience [37].
– Strength and Difficulties Questionnaire (SDQ).
The validated SDQ has two versions, one for
parents (7–19 years) and one for children (11 years
and over), which were developed using the
‘diagnostic and static manual of mental disorders
classification’ for psychosocial problems, as these
problems (anxiety, depression, behavioural disorders
and attention deficit hyperactivity disorders) are
relatively common among young people. The total
score ranges from 0 to 40 points, with established
cut-off points at 0–10 (normal), 11–13 (borderline,
presence of less serious issues) and above 14
(high) [38-40].
– Global perceived effect
The global perceived effect (GPE) instrument is a
subjective score that simply shows the perceived
change in symptoms during and after treatment,
ranging from 1 (much worse) to 9 (complaints
have disappeared). The GPE will be administered
at MT-WB 2 and MT-WB 3 before the final visit
to the physiotherapist.
– Pelvic floor muscle function
The following measurements will be done by the
physiotherapist at the second (MT-PPT 1) and
final visit (MT-PPT 2). Digital testing
Digital testing will be used to measure the
ability and reflex action of the pelvic floor
muscles (PFM) at rest and during contraction,
cough and straining to defecate. The tone of
the internal and external anal sphincters and
puborectalis muscle will be palpated, and the
sensitivity, anal reflex and presence of stool
evaluated. Strength, endurance, coordination
and the ability to close the rectum will be
evaluated by asking the child to contract and
relax the PFM, and then to hold the
contraction for 30 seconds. At the same time,
the pelvic physiotherapist will assess whether
the child is contracting the extra-pelvic
muscles, like the abdominal, gluteal and
adductor muscles.
 Myofeedback
Myofeedback uses the electromyographic (EMG)
signal of the pelvic floor muscles. The level of
the EMG signal should increase while
contracting, whereas the signal should decrease
at relaxation [15,17,41,42]. Given the absence of
an assessment instrument to define proper
muscle tone of children's pelvic floor, parameters
for the male adults will be used [28,29,36,43].
For the purpose of this study, the small intra-
anal PelviRing Anal Probe will be used.
The baseline tone of the puborectalis, the
maximum strength, and maximum strength
after 30 seconds, the tone during straining, the
fast and slow twitch and the ability to relax will
be measured.
Values are considered abnormal when: (1) The
resting tone is higher than 5 μV (hypertonic) or
lower than 2 μV (hypotonic), (2) the sub
maximal strength after 30 seconds is not equal
to the resting tone, (3) the tone during
straining is over 5 μV, (4) onset over 0.2
seconds, (5) offset over 0.2 seconds, (6) the
resting tone after testing is higher than 5 μV
and (7) the tone fluctuates.
 Rectal Balloon Catheter
Rectal balloon training (RBT) will be used to
develop awareness of the sensory threshold and
to strain in a proper way. A neoprene rectal
balloon attached to a syringe will be introduced
into the rectum and slowly inflated with air to
imitate rectal contents. Next, the child will be
requested to excrete the balloon, as it would do
during defecation. Attention will be paid to the
effect of the pelvic floor muscles on sensory
threshold, urge sensation, maximum tolerated
volume and straining. Satisfactory (reflex)
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overreactions of the pelvic floor muscles and of
the extra-pelvic muscles like those of the trunk,
legs, arms or head are recorded at first
sensation, urge and maximum urge. The
method of straining is left to the child. The
ability to strain sufficiently to defecate is
recorded. Absence of reaction of the external
anal sphincter, immediately before or at sensory
threshold, urge and maximum tolerated
volume, will be considered abnormal, as are
overreactions of the pelvic floor muscles or the
extra-pelvic muscles at straining.Power of the study
The sample size of this study has been calculated on the
basis of a clinical difference of minimal relevance in
terms of proportions. The success rate (absence of FC)
of the controls has been set at 60% [30,44-46]. There is
no published PPT success rate but it is estimated to be
75%. Based on a two-sided effect, an alpha of 0.05, a
power of 80% and an expected drop-out rate of 20%, at
least 367 children should be enrolled in this study.
Randomisation and blinding
Randomisation will be based on a list of random num-
bers generated by a computer in a 1:1 ratio. Concealed
randomisation will take place immediately after the sec-
ond visit to the physiotherapist. Blinding of practitioners,
children and outcome assessor is impossible. However, the
investigator and parents are blinded for the web-based
and PPT baseline measurements and the diary data.
Data analysis
After checking for missing data and testing for normal-
ity, group differences will be analysed using the Pearson
Chi-square test, or likelihood ratio in the case of dichot-
omous outcomes. Continuous outcomes will be analysed
using the independent samples t-test or the Mann–
Whitney U test. Adjusted group differences will be
analysed using multivariable logistic regression with or-
dinal variables transformed into dummies, taking into
account possible differences in mean number of sessions.
Finally, subgroup analyses will be done to establish nor-
mal values and observed differences in effectiveness for
relevant clinical subgroups.
Data analysis will be done according to the intention-
to-treat principle. Characteristics of the study population
at baseline will be described. Potential effect modifiers
like age and gender [10,14], as well as potential con-
founders like urinary incontinence, enuresis and abdom-
inal pain will be taken into account [17,47-51]. To assess
selection bias, responders and nonresponders will be
compared in terms of relevant clinical and demographicvariables. Data analysis will be carried out using SPSS
version 19.0 (SPSS Inc., Chicago, Illinois). A two-tailed
p-value of 0.05 will be considered statistically significant.
Discussion
Why publish a study protocol? This study aims to show
that pelvic physiotherapy in combination with standard
medical care is more effective than standard medical
care alone in constipated children. To our knowledge,
this article is the first to describe the design of an RCT
among children with FC to assess the effect of PPT as an
add-on to SMC. The Dutch Pelvic Physiotherapy Proto-
col (DPPP) presented here is based on the available lit-
erature, a survey and a Delphi procedure among experts.
Exchanging knowledge and expertise with other re-
searchers is important in order to prevent duplicate re-
search. Consequently, it has been decided to publish the
study protocol prior to achieving results.
The DPPP was developed between 2007 and 2009.
Given that no studies have so far been published on the
effect of PPT in childhood constipation [52] and that a
repeat survey on standard PPT among 49 Dutch physio-
therapists in 2011 did not yield substantial differences
compared to the 2007 survey, we feel this protocol is as
up-to-date as possible.
In the absence of an evaluation tool, we will use pa-
rameters for male adults to define the proper childhood
pelvic floor muscle functions. These values are expected
to be similar to the children’s, as is also the opinion of
the experts and the literature [36].
Confounding in our trial may arise due to the
Hawthorne-effect as a result of differences in number of
the protocolised contacts. Although it is expected, based
on experience, that the mean number of treatment ses-
sions will be equal, adjusted group differences will be
analysed.
Biofeedback, as a modality of PPT, is an umbrella term
in the literature, covering different types of treatment, e.g.
manometry (MT), myofeedback (electromyography feed-
back) (MFB), rectal balloon training (RBT), functional
electric stimulation, flowmetry and ultrasound scan. It is
administered in various ways depending on availability,
costs, setting (clinic/private, discipline involved [physio-
therapist/nurse/medical doctor]) and country. There are
also differences in the biofeedback method used (peri-anal
surface electrodes, intra-anal probes, anal manometry or
RBT), the practitioner administering it (gastroenterologist,
paediatrician or psychologist), number of treatments and
outcome [53-58]. Furthermore, trials show a substantial
lack of quality and harmonisation, resulting in het-
erogeneous treatment protocols and difficulties when
interpreting the findings reported in the literature. Mixed
results of BF treatment for constipation have been
reported [24,54,57,59,60].
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lonic transit can manifest itself as a single or combined
problem [61]. The behavioural approach, concentrating
on toilet training and learning to recognise signals from
the body such as the urge to defecate, is important for
all constipated children [18]. To date, the relationship
between pelvic floor muscles, breathing, trunk control
and posture [21,22,25,26] has been largely ignored.
Therefore, we feel that PFM training must be included
in the treatment and should be the starting point of the
therapy, rather than being studied as a single modality.
In order to standardise pelvic physiotherapy and min-
imise information bias, the treatment protocol has been
designed in consultation with all participating specialised
physiotherapists, who are experienced in treating consti-
pated children.
As with most physiotherapeutic and medical interven-
tions, the practitioner and patient will not be blinded to
the treatment interventions. However, the investigator
and patient will be blinded for the web-based and PPT
baseline measurements and diary data.
Potential confounders will be the presence of urinary
incontinence, enuresis, abdominal pain and the use of
laxatives [1,18,47]. The presence of incontinence, enur-
esis and pain can influence the perception of patients'
quality of life or may distort the SDQ and GPE scores.
Patients' compliance with the home toilet training and
the use of laxatives will be monitored, as it determines
the therapy intensity and, indirectly, the success of the
therapy. Finally, the use of laxatives will be taken into
account, as it can influence the number of stool events
and consistency. The results of this trial will be used to
evaluate the proposed Dutch pelvic physiotherapy proto-
col and to determine normal values for the pelvic floor
muscle function in children. These outcomes will serve as
recommendations in the guideline on PPT in constipated
children, which will be developed using the standard
method for clinical practice guideline development of the
Royal Dutch Society for Physical Therapy (KNGF).Endnote
The web-based medical software had been developed
by Fastguide, Bergen op Zoom, the Netherlands.
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